Company Filing History:
30 out of 125 
9 out of 29 
6 out of 15 
Years Active: 2017-2025
Title: Jennifer R Thomason: A Prolific Inventor in HDAC Inhibitor Therapeutics
Introduction:
In the world of pharmaceutical innovation, researchers and inventors play a crucial role in developing new treatments that alleviate diseases' burdens. Among these dedicated individuals is Jennifer R Thomason, a talented inventor hailing from Clinton, MA. With an impressive track record of 43 patents, Thomason has made notable contributions to the field of histone deacetylase (HDAC) inhibitor therapeutics. In this article, we delve into her latest patents, career highlights, and collaborations that have shaped her success.
Latest Patents:
Jennifer R Thomason's recent patents demonstrate her expertise in developing inhibitors of zinc-dependent HDACs, particularly HDAC6. Her research focuses on finding treatments for diseases and disorders associated with HDACs. Two of her most recent patents include:
1. "3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors": This patent highlights compounds that have demonstrated inhibitory effects on HDAC6. These compounds show potential for treating various diseases associated with abnormal HDAC activity.
2. "Isoindolines as HDAC inhibitors": Thomason's invention involves a new class of compounds effective in inhibiting zinc-dependent HDACs. These compounds exhibit promising therapeutic potential for combating HDAC-related diseases.
Career Highlights:
Jennifer R Thomason has contributed significantly to the field of HDAC inhibitor therapeutics throughout her career. Some of her notable career highlights include her involvement with renowned companies:
1. Forma Therapeutics, Inc.: Thomason has found a professional home at Forma Therapeutics, Inc., a leading biopharmaceutical company dedicated to developing transformative medicines. Her work at Forma Therapeutics has contributed to the advancement of HDAC inhibitor research and the potential for groundbreaking therapies.
2. Valo Health, Inc.: Thomason has also made significant contributions during her tenure at Valo Health, Inc. This innovative company aims to revolutionize drug discovery and development by integrating data science, machine learning, and biology. Thomason's expertise has greatly supported Valo Health's vision for cutting-edge treatments.
Collaborations:
Collaboration is instrumental in pushing the boundaries of innovation, and Jennifer R Thomason has actively collaborated with fellow researchers and inventors to propel groundbreaking inventions. Notable colleagues she has worked with include:
1. Xiaozhang Zheng: Thomason has collaborated with Xiaozhang Zheng, combining their expertise in the field of HDAC inhibition. Their collaboration has strengthened the development of novel HDAC inhibitors and paved the way for potential therapeutic breakthroughs.
2. Bingsong Han: Another noteworthy collaboration in Thomason's journey is with Bingsong Han. Together, they have explored new avenues in HDAC inhibitor research, pooling their knowledge to push the boundaries of therapeutic possibilities.
Conclusion:
In the pursuit of developing innovative treatments through HDAC inhibitor therapeutics, Jennifer R Thomason has emerged as a distinguished inventor. With an impressive array of patents and a career enriched by collaborations with influential companies and esteemed colleagues, Thomason's contributions in HDAC inhibition research are invaluable. Her dedication to advancing the field promises a brighter future for patients suffering from diseases associated with HDAC dysregulation.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.